Cargando…
Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides
Telavancin was discovered by modifying the chemical structure of vancomycin and belongs to the group of lipoglycopeptides. It employs its antimicrobial potential through two distinct mechanisms of action: inhibition of bacterial cell wall synthesis and induction of bacterial membrane depolarization...
Autores principales: | al Jalali, Valentin, Zeitlinger, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999141/ https://www.ncbi.nlm.nih.gov/pubmed/29332251 http://dx.doi.org/10.1007/s40262-017-0623-4 |
Ejemplares similares
-
Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents
por: al Jalali, Valentin, et al.
Publicado: (2020) -
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review
por: Jorda, Anselm, et al.
Publicado: (2020) -
Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time–Kill Approaches
por: van Os, Wisse, et al.
Publicado: (2021) -
Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of antibiotics: A reality check
por: Zeitlinger, Markus, et al.
Publicado: (2023) -
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
por: Bressler, Adam M., et al.
Publicado: (2019)